About
Deanna is a broadly skilled senior executive with leadership experience in global business development and strategic planning. Deanna previously was the head of business development for Shire’s rare disease business where she and her team identified and evaluated new business opportunities, and negotiated and executed more than 40 transactions in 5 years (public and private M&A, licenses and other partnerships), including a $4.2 billion dollar acquisition of ViroPharma. Prior to joining Shire, Deanna was Vice President of Business Development at Agenus Inc. and at Coley Pharmaceutical Group. Deanna is on the Board of Directors for American DG Energy and for the Massachusetts Biotechnology Association, and previously for the Healthcare Businesswomen’s Association, Boston Chapter.
Position in the VCSift Database
- • 2 investors at Avrobio are tracked.
- • 3 investors hold the Chief Business Officer role in VCSift. Deanna Petersen is one of them.
- • 491 investors are based in Cambridge, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Cambridge, US
Contact Information
Find more investors like Deanna
Search Investors